Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

mRNA vaccines in disease prevention and treatment
Gang Zhang, Tianyu Tang, Yinfeng Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 107

Showing 1-25 of 107 citing articles:

Clinical advances of mRNA vaccines for cancer immunotherapy
Alexey V. Yaremenko, Muhammad Muzamil Khan, Xueyan Zhen, et al.
Med (2025) Vol. 6, Iss. 1, pp. 100562-100562
Closed Access | Times Cited: 4
Boosting CAR-T cell therapy through vaccine synergy
Yan-Ruide Li, Zibai Lyu, Xinyuan Shen, et al.
Trends in Pharmacological Sciences (2025)
Open Access | Times Cited: 2
An Overview of Nanoparticle-Based Delivery Platforms for mRNA Vaccines for Treating Cancer
Lin Yang, Xuehua Chen, Ke Wang, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 727-727
Open Access | Times Cited: 14
The interaction of innate immune and adaptive immune system
Ruyuan Wang, Caini Lan, Kamel Benlagha, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 14
The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV)
Fatemeh Movahed, Satinik Darzi, Parya Mahdavi, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 12
Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategies
Niloofar Faraji, Tahereh Zeinali, Farahnaz Joukar, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30208-e30208
Open Access | Times Cited: 11
Exploring precision treatments in immune‐mediated inflammatory diseases: Harnessing the infinite potential of nucleic acid delivery
Lingxiao Xu, Z. Shao, Xia Fang, et al.
Exploration (2024)
Open Access | Times Cited: 10
Advancing Therapeutic Strategies with Polymeric Drug Conjugates for Nucleic Acid Delivery and Treatment
Aftab Ullah, Marina Khan, Yibang Zhang, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 25-52
Open Access | Times Cited: 1
mRNA vaccines in the context of cancer treatment: from concept to application
Qiang Fu, Xiaoming Zhao, Jinxia Hu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Advances in nucleic acid-based cancer vaccines
Hung‐Chun Liao, Shih‐Jen Liu
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access | Times Cited: 1
Humoral and cellular immune durability of different COVID-19 vaccine platforms following homologous/heterologous boosters: one-year post vaccination
Maaweya Awadalla, Halah Z. AlRawi, Rahaf A. Henawi, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy
Dariush Haghmorad, Majid Eslami, Niloufar Orooji, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access | Times Cited: 1
Revolutionizing Drug Delivery: The Impact of Advanced Materials Science and Technology on Precision Medicine
Mohamed El‐Tanani, Shakta Mani Satyam, Syed Arman Rabbani, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 375-375
Open Access | Times Cited: 1
Recent Findings on Therapeutic Cancer Vaccines: An Updated Review
Sara Sheikhlary, David Humberto Lopez, Sophia Moghimi, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 503-503
Open Access | Times Cited: 7
Lipid nanoparticles as the drug carrier for targeted therapy of hepatic disorders
Runxuan Chu, Yi Wang, Jianglong Kong, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 20, pp. 4759-4784
Closed Access | Times Cited: 7
mRNA vaccines: a new era in vaccine development
Shubhra Chandra, Jennifer C Wilson, David M. Good, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 10, pp. 1543-1564
Open Access | Times Cited: 7
Recent Advancements in mRNA Vaccines: From Target Selection to Delivery Systems
Zhongyan Wu, Weilu Sun, Hailong Qi
Vaccines (2024) Vol. 12, Iss. 8, pp. 873-873
Open Access | Times Cited: 7
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 7
Advancements in monkeypox vaccines development: a critical review of emerging technologies
Igor Garcia-Atutxa, Paul Mondragón‐Terán, Alejandro Huerta‐Saquero, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Cancer vaccines: Target antigens, vaccine platforms and preclinical models
Francesca Ruzzi, Federica Riccardo, Laura Conti, et al.
Molecular Aspects of Medicine (2024) Vol. 101, pp. 101324-101324
Open Access | Times Cited: 6
Tailoring Biomaterials Ameliorate Inflammatory Bone Loss
Shi Cheng, Kong‐Huai Wang, Lu Zhou, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 12
Closed Access | Times Cited: 5
Emerging advances in delivery systems for mRNA cancer vaccines
Zhimei Jiang, Yanhua Xu, Guangsheng Du, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 287-301
Closed Access | Times Cited: 5
mRNA-based vaccines – global approach, challenges, and could be a promising wayout for future pandemics
Shivani Makhijani, Gehan M. Elossaily, Satish Rojekar, et al.
Pharmaceutical Development and Technology (2024) Vol. 29, Iss. 6, pp. 559-565
Closed Access | Times Cited: 5
pH‐Responsive β‐Glucans‐Complexed mRNA in LNPs as an Oral Vaccine for Enhancing Cancer Immunotherapy
Po‐Kai Luo, Hui‐Min Ho, Min‐Chun Chiang, et al.
Advanced Materials (2024) Vol. 36, Iss. 33
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top